Pulse Biosciences Cash Flow Statement (2015-2025) | PLSE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-20.57M-20.31M-14.94M-15.46M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M87.80M-16.80M-19.17M-29.96M
Depreciation and Depletion (Quarter)
0.10M0.10M0.10M0.13M0.16M0.10M0.20M0.20M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.12M0.12M0.10M0.10M0.09M
Share-based Compensation (Quarter)
4.20M2.45M1.58M-0.40M2.01M1.71M0.72M0.90M1.14M1.80M-65.25M1.76M2.05M2.98M6.79M5.68M5.19M5.62M-16.49M
Deferred Taxes (Quarter)
Asset Writedowns and Impairment (Quarter)
1.11M
Cash from Operations (Quarter)
-11.69M-16.37M-13.35M-12.69M-15.59M-12.82M-10.63M-7.96M-6.57M-9.20M-10.49M-6.78M-9.78M-8.39M-9.02M-9.14M-13.52M-12.81M-13.04M-14.76M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
0.23M0.26M0.29M0.31M
Depreciation & Amortization (CF) (Quarter)
0.10M0.10M0.10M0.13M0.16M0.10M0.20M0.20M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.12M0.12M0.10M0.10M0.09M
Change in Working Capital
Change in Receivables (Quarter)
-0.01M-0.04M-0.01M-0.00M-0.01M0.26M
Change in Inventory (Quarter)
1.14M1.56M1.59M1.54M1.66M0.38M0.25M0.36M0.03M0.02M0.01M0.08M
Change in Account Payables (Quarter)
0.43M0.61M-0.07M0.18M0.61M-1.54M0.04M-0.41M0.59M-0.38M-0.39M0.44M-0.12M-0.16M0.09M-0.01M0.71M0.33M0.27M-0.19M
Change in Accured Expenses (Quarter)
0.29M0.34M-0.61M0.64M0.00M-1.79M0.50M-0.26M0.17M0.81M-1.55M0.91M0.64M3.21M-3.04M0.79M0.43M-1.63M
Other Working Capital Changes (Quarter)
0.12M2.33M-0.37M-0.71M-0.19M-0.92M0.17M-0.22M-0.16M0.47M0.03M-0.28M-0.01M0.09M0.31M-0.04M0.27M0.15M0.12M0.37M
Investing Activities
Capital Expenditures (Quarter)
0.05M0.10M0.16M-0.28M0.03M0.27M0.06M0.04M0.04M0.02M0.02M0.04M0.02M-0.02M0.03M0.03M-0.00M0.19M0.10M
Change in Acquisitions & Divestments (Quarter)
8.00M
Cash from Investing Activities (Quarter)
7.95M-0.10M-0.16M-0.13M-0.28M-0.02M-0.06M-0.04M-0.04M-0.02M-0.02M-0.04M-0.01M-0.03M-0.04M-0.05M-0.04M-0.12M-0.06M-0.10M
Financing Activities
Other financing activities (Quarter)
0.62M3.60M-3.41M0.48M-0.48M0.29M-14.51M0.78M0.30M-0.30M0.48M0.38M13.68M0.02M0.02M
Cash from Financing Activities (Quarter)
51.16M4.00M8.07M-0.55M-0.07M14.96M65.06M-0.02M-0.43M13.87M2.15M0.80M0.30M-0.27M61.90M48.20M14.81M1.97M0.38M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
4.89M8.40M8.35M-0.07M-0.03M
Additional items
Change in Cash (Quarter)
47.42M-12.46M-5.43M-13.38M-15.94M2.12M54.36M-8.02M-7.04M4.65M-8.36M-6.02M-9.48M-8.69M52.84M39.01M1.24M-12.93M-11.13M-14.48M
Free Cash Flow (Quarter)
-11.74M-16.46M-13.51M-12.42M-15.62M-13.09M-10.69M-8.01M-6.61M-9.22M-10.51M-6.83M-9.78M-8.41M-9.01M-9.18M-13.55M-12.80M-13.22M-14.86M
Net Cash Flow (Quarter)
47.42M-12.46M-5.43M-13.38M-15.94M2.12M54.36M-8.02M-7.04M4.65M-8.36M-6.02M-9.48M-8.69M52.84M39.01M1.24M-12.93M-11.13M-14.48M